MedTrace Logo

Validation of a Seizure Monitoring System

NCT03465189 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2020-10-27

No results posted yet for this study

Summary

The investigators aim to determine the feasibility of using the Medtronic LINQ device for epilepsy diagnosis, monitoring and management. The feasibility will be determined by comparing EEG signals from the LINQ system to the gold standard clinical recordings. If seizures can be identified using the LINQ device with the same level of accuracy as adjacent scalp EEG recording electrodes, then the LINQ will be deemed feasible.

Conditions

Interventions

DEVICE

Medtronic LINQ Device

Using two LINQ devices that are fixed to scalp to record EEG (in addition to the standard scalp EEG).

Sponsors & Collaborators

  • University of Melbourne

    collaborator OTHER

  • Seer Medical

    collaborator UNKNOWN

  • St Vincent's Hospital Melbourne

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-10
Primary Completion
2019-03-19
Completion
2020-03-19
FDA Device
Yes

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03465189 on ClinicalTrials.gov